Shopping Cart
- Remove All
- Your shopping cart is currently empty
mCherry-mRNA is an mRNA molecule capped at the 5' end, polyadenylated at the 3' end, and modified with N1-Me-Pseudo UTP, mimicking the processed mature mRNA found in eukaryotes. The mRNA is capped co-transcriptionally using 3'-O-Me-GAG, forming a Cap1 structure which enhances mRNA stability and translation efficiency. The incorporation of the modified nucleotide N1-Me-Pseudo UTP reduces innate immune stimulation and increases mRNA stability. The addition of the poly(A) tail further stabilizes the mRNA and enhances its translation initiation efficiency.
Description | mCherry-mRNA is an mRNA molecule capped at the 5' end, polyadenylated at the 3' end, and modified with N1-Me-Pseudo UTP, mimicking the processed mature mRNA found in eukaryotes. The mRNA is capped co-transcriptionally using 3'-O-Me-GAG, forming a Cap1 structure which enhances mRNA stability and translation efficiency. The incorporation of the modified nucleotide N1-Me-Pseudo UTP reduces innate immune stimulation and increases mRNA stability. The addition of the poly(A) tail further stabilizes the mRNA and enhances its translation initiation efficiency. |
In vitro | CD5/LNP-mCherry(1 µg) was added per million cells, and mCherry expression was measured by flow cytometry 24 h later. Resting T cells showed low expression (~12%), but activation with αCD3/CD28 beads dramatically increased it to 75-80%[1]. |
In vivo | Naive mice received 10 µg CD5/LNP-mCherry intravenously, and flow cytometry 24 hours later revealed mCherry expression in 5–15% of splenic and lymph node CD4⁺/CD8⁺ T cells[1]. |
Storage | store at -80°C for 2 years |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.